Tianjin Lisheng Pharmaceutical Co. Ltd. announced that at its extraordinary general meeting held on September 05, 2017, approved the election of Qi Tieshuan as a director, election of Li Yan as a supervisor, and removal of Zhang Jianjin as a director.